Search
for
Sort by
Research 781–810 of 1000+
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- Parkinson's disease and skin
- Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process
- Innovative Uses for Zinc in Dermatology
- The Aging Face
- Contraception and the dermatologist
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Limited stage small cell lung cancer
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Caffeine content in newborn hair correlates with maternal dietary intake
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Update on Frontal Fibrosing Alopecia
- Adipose-Derived Stem/Stromal Cells
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Caring for women with polycystic ovary syndrome
- Gene Therapy: Recent Advances and Applications in Dermatology
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Scalp Bacterial Microbiota Dysbiosis in Androgenetic Alopecia: Community Structure, Functional Profiles, and Associations with Lifestyle Factors
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- Abstracts
- Fibrosing Frontal Alopecia: A comprehensive study to understand its etiology